A von Willebrand disease panel checks whether your blood has enough working von Willebrand factor, the clotting protein that helps platelets stick to damaged blood vessels and carries factor VIII in the bloodstream. The panel usually includes vWF antigen, vWF activity, and factor VIII activity. These results help explain easy bruising, frequent nosebleeds, heavy menstrual bleeding, bleeding after dental work or surgery, and a family history of bleeding problems.
The panel does not work like a simple positive-or-negative test. vWF levels shift with stress, inflammation, pregnancy, hormones, blood type, age, and recent bleeding. A low or borderline result often needs repeat testing when you are well and at your usual baseline. The pattern matters more than one number: antigen shows the amount of vWF, activity shows how well it works, and factor VIII shows whether vWF is supporting a key clotting factor.
- A von Willebrand disease panel usually measures vWF antigen, vWF activity, and factor VIII activity. Some labs add vWF multimers, collagen binding, or specialized subtype tests.
- Low vWF antigen usually means reduced vWF quantity. This pattern fits type 1 VWD when bleeding symptoms and repeat results support the diagnosis.
- Low vWF activity with a normal or less-reduced antigen level suggests a function problem. An activity-to-antigen ratio below about 0.7 often raises concern for type 2 VWD.
- Low factor VIII occurs because vWF protects factor VIII from breakdown. Very low factor VIII also raises the need to distinguish VWD from hemophilia A.
- Typical vWF reference ranges are often around 50–200 IU/dL or 50–200%, but each lab sets its own range. Results below 30 IU/dL strongly support VWD; 30–50 IU/dL needs bleeding history and clinical context.
- Testing is best done when you are not acutely ill, pregnant, immediately after surgery, or under major physical stress. These states raise vWF and hide mild deficiency.
Table of Contents
- What the von Willebrand Disease Panel Measures
- When a vWF Panel Is Needed
- How to Prepare and Why Timing Matters
- Normal Ranges, Borderline Results, and Diagnostic Cutoffs
- How to Read Common Result Patterns
- How the Panel Helps Identify VWD Types
- What Results Mean for Bleeding Risk and Procedures
- Follow-Up Tests, Repeat Testing, and Next Steps
What the von Willebrand Disease Panel Measures
A von Willebrand disease panel measures the amount and function of von Willebrand factor, often shortened to vWF or VWF, and checks factor VIII activity. These three tests work together because von Willebrand factor has two major jobs in normal clotting.
First, it helps platelets attach to the damaged blood vessel wall. Platelets are small blood cells that form the first plug after an injury. Without enough working vWF, platelets do not stick as well, so bleeding from small blood vessels lasts longer.
Second, vWF carries and protects factor VIII. Factor VIII is a clotting protein needed for the clotting cascade, the chain reaction that strengthens the platelet plug with fibrin. When vWF is very low or does not bind factor VIII correctly, factor VIII activity drops.
The standard first-line panel usually includes:
| Test | What it measures | Why it matters |
|---|---|---|
| vWF antigen | The amount of von Willebrand factor protein in blood | Shows whether the body has enough vWF |
| vWF activity | How well vWF binds to platelets or platelet receptors | Shows whether vWF works properly |
| Factor VIII activity | The clotting activity of factor VIII | Shows whether vWF is supporting factor VIII and helps separate VWD from other clotting disorders |
vWF antigen answers the question, “How much vWF is present?” vWF activity answers the question, “Does the vWF work?” Factor VIII answers the question, “Is a key clotting factor low because vWF is low or abnormal?”
Older reports often list vWF activity as ristocetin cofactor activity or VWF:RCo. Newer laboratories increasingly use activity tests based on platelet glycoprotein Ib binding, often written as VWF:GPIbM or VWF:GPIbR. These newer assays often give more precise results, especially at low levels. The exact method matters because different assays do not always give identical values.
A basic coagulation panel does not rule out von Willebrand disease. PT is usually normal in VWD. aPTT is normal in many people with VWD and becomes prolonged mainly when factor VIII is low enough. That is why specific vWF testing is needed when the bleeding history points toward a platelet-type or mucosal bleeding disorder.
When a vWF Panel Is Needed
A vWF panel is ordered when the bleeding pattern suggests a problem with platelet adhesion or von Willebrand factor. The most common clues involve bleeding from skin and mucous membranes rather than deep muscle bleeding.
Common reasons for testing include:
- Frequent nosebleeds that last longer than expected or need medical treatment
- Easy bruising, especially large bruises from minor bumps
- Heavy menstrual bleeding, flooding, large clots, anemia, or needing double protection
- Bleeding after tooth extraction, tonsillectomy, childbirth, surgery, or injury
- Bleeding that restarts after initially stopping
- Prolonged bleeding from small cuts
- A known family history of von Willebrand disease
- A child with repeated bleeding symptoms and relatives with similar problems
- Unexpected low factor VIII or prolonged aPTT on earlier testing
Heavy menstrual bleeding is one of the most common reasons the panel is ordered. Clues that menstrual bleeding deserves evaluation include bleeding through pads or tampons in 1–2 hours, periods lasting more than 7 days, passing clots larger than a quarter, iron deficiency, or needing emergency care. A low hemoglobin result or low ferritin strengthens the case for looking for a bleeding disorder.
Testing also matters before procedures when the history suggests bleeding risk. A person with years of nosebleeds, heavy periods, and bleeding after dental work needs a different preoperative plan than someone with no bleeding history. A normal platelet count or normal PT does not erase that history.
Doctors often use a structured bleeding history or bleeding assessment tool before ordering the panel. These tools ask about bleeding severity, not just whether bleeding happened. For example, “nosebleeds” means more when they lasted longer than 10 minutes, caused anemia, required packing, or led to medical visits.
Testing is less useful as a broad screening test in people with no bleeding symptoms and no family history. Mildly low vWF values occur in otherwise healthy people, especially those with blood type O. Testing without a strong clinical reason increases false alarms, repeat testing, anxiety, and uncertain labels.
How to Prepare and Why Timing Matters
You usually do not need to fast for a von Willebrand disease panel. The blood draw is taken from a vein, and the sample must be handled carefully because clotting proteins are sensitive to collection and processing problems.
The most important preparation is timing. vWF is an acute-phase reactant, which means levels rise during physical stress, inflammation, infection, injury, surgery, and pregnancy. Testing during these states gives a result that looks more normal than your usual baseline. Mild VWD or low vWF is easiest to miss when the body has temporarily raised vWF.
Tell the ordering clinician or laboratory about:
- Current infection, fever, inflammation, or recent vaccination
- Recent surgery, trauma, childbirth, or major bleeding
- Pregnancy or recent postpartum status
- Estrogen-containing birth control or hormone therapy
- Desmopressin use
- vWF concentrate or factor replacement treatment
- Blood transfusion or plasma products
- Intense exercise shortly before the test
- Blood type, if known
- Current anticoagulants, antiplatelet drugs, or high-dose nonsteroidal anti-inflammatory drugs
Estrogen and pregnancy often raise vWF. This does not mean people using hormonal contraception cannot be tested, but the result needs context. In some cases, clinicians test while the person is on current therapy because the practical question is procedure planning. In other cases, they repeat testing later to understand the baseline.
Recent desmopressin or vWF concentrate makes results hard to interpret for diagnosis. Desmopressin, also called DDAVP, releases stored vWF from blood vessel lining cells. It is useful as treatment for selected patients, but diagnostic testing after recent desmopressin does not show the untreated baseline.
Sample quality matters too. Underfilled tubes, clotting in the tube, delayed processing, wrong storage temperature, and transport problems all distort clotting tests. If the result does not match the bleeding history, repeating the panel at a laboratory experienced in coagulation testing is often the cleanest next step.
Normal Ranges, Borderline Results, and Diagnostic Cutoffs
Most laboratories report vWF antigen, vWF activity, and factor VIII activity as IU/dL or as a percentage. In practical terms, 100 IU/dL often equals 100% activity or level, though each laboratory uses its own calibration and reference interval.
Common reference ranges look like this:
| Marker | Common adult reference range | Important interpretation point |
|---|---|---|
| vWF antigen | About 50–200 IU/dL | Low values show reduced amount of vWF |
| vWF activity | About 50–200 IU/dL | Low values show reduced platelet-binding function |
| Factor VIII activity | About 50–150 or 50–200 IU/dL | Low values occur in VWD and hemophilia A |
The exact range on your report matters more than any general range. Laboratories use different instruments, reagents, and activity methods. A result of 48 IU/dL looks “low” in many labs but sits close enough to the cutoff that repeat testing and bleeding history matter.
A useful way to think about vWF levels is:
| vWF level | Common meaning | Clinical note |
|---|---|---|
| 50 IU/dL or higher | Usually within the expected range | Does not fully exclude VWD when suspicion is strong or testing occurred during stress, illness, pregnancy, or inflammation |
| 30–50 IU/dL | Low vWF or possible type 1 VWD | Bleeding history, family history, repeat results, and procedure risk guide interpretation |
| Below 30 IU/dL | Strongly supports VWD | Usually treated as clinically significant, especially with bleeding symptoms or family history |
| Very low or undetectable | Concern for severe VWD, especially type 3 | Needs specialist evaluation and detailed subtype testing |
Borderline results are common because vWF levels vary naturally. Blood type O is linked with lower average vWF levels than non-O blood types. Age, inflammation, pregnancy, and estrogen exposure tend to raise levels. A person with true bleeding symptoms and vWF activity of 42 IU/dL deserves a different interpretation than a person with the same result found during unrelated screening.
The activity-to-antigen ratio is a key calculation. It compares function with quantity:
- A ratio around 0.7 or higher usually means activity and antigen are reduced together, which fits a quantity problem such as type 1 VWD.
- A ratio below about 0.7 suggests vWF function is reduced more than the amount, which raises concern for type 2 VWD.
- A very low factor VIII compared with vWF antigen raises concern for type 2N VWD or hemophilia A.
For a deeper look at a single marker, a separate vWF antigen reference range guide helps explain how antigen values are reported and why “normal” varies by lab.
How to Read Common Result Patterns
The panel is interpreted by pattern, not by one isolated number. The same vWF antigen value means different things when activity, factor VIII, bleeding history, and repeat testing point in different directions.
Low antigen and low activity in a similar proportion
When vWF antigen and vWF activity are both low to a similar degree, the main issue is usually reduced quantity. The body has less vWF than expected, but the vWF that is present works in proportion to its amount.
Example pattern:
- vWF antigen: 32 IU/dL
- vWF activity: 30 IU/dL
- Activity-to-antigen ratio: about 0.94
- Factor VIII: mildly low or normal
This pattern fits type 1 VWD or low vWF, depending on the exact level, bleeding symptoms, and repeat results. Type 1 VWD is the most common form. It often causes mucosal bleeding, heavy menstrual bleeding, bruising, and procedure-related bleeding, but severity varies widely.
Activity much lower than antigen
When vWF activity is much lower than vWF antigen, the amount of vWF is not the whole problem. The protein is present, but it does not work normally.
Example pattern:
- vWF antigen: 65 IU/dL
- vWF activity: 28 IU/dL
- Activity-to-antigen ratio: about 0.43
- Factor VIII: normal or mildly low
This pattern raises concern for type 2 VWD. The next step often includes vWF multimer analysis, collagen-binding testing, repeat activity testing with a modern assay, platelet count review, and sometimes genetic testing.
A separate vWF activity test discussion is useful when the main abnormal result is low function rather than low antigen.
Very low factor VIII with low or abnormal vWF results
Factor VIII drops in many forms of VWD because vWF protects factor VIII. A mild reduction supports the diagnosis when vWF antigen or activity is low. A marked reduction needs careful review.
Example pattern:
- vWF antigen: 45 IU/dL
- vWF activity: 42 IU/dL
- Factor VIII: 12 IU/dL
This pattern raises the possibility of type 2N VWD, where vWF does not bind factor VIII properly. It also raises the possibility of mild hemophilia A. The distinction matters because inheritance, counseling, and treatment plans differ. Specialized vWF-factor VIII binding tests or genetic testing often clarify the diagnosis.
Normal panel but strong bleeding history
A normal vWF panel reduces the chance of VWD, but it does not always end the evaluation. Results look falsely reassuring when testing happens during pregnancy, acute illness, inflammation, after surgery, or after desmopressin. Mild VWD also fluctuates around the lower end of normal.
When symptoms are convincing, clinicians often repeat the panel at baseline and look for other causes, such as platelet function disorders, low platelet count, medication effects, connective tissue disorders, or other factor deficiencies. A platelet function test becomes relevant when bruising and mucosal bleeding persist despite normal vWF results.
High vWF antigen or activity
High vWF is not used to diagnose von Willebrand disease. vWF rises with inflammation, infection, stress, pregnancy, aging, liver or vascular inflammation, and some chronic conditions. High factor VIII and high vWF have also been linked with clotting tendency in some settings, but the clinical meaning depends on the whole situation.
A high result during an acute illness should not be used to rule out a lifelong mild bleeding disorder. If the goal is to evaluate bleeding symptoms, repeat testing after recovery is often more informative.
How the Panel Helps Identify VWD Types
Von Willebrand disease is grouped by whether the problem is low amount, abnormal function, or near absence of vWF. The first panel points toward the type, but it does not always finish the subtype diagnosis.
| Type | Main problem | Typical panel pattern | Why subtype matters |
|---|---|---|---|
| Type 1 | Partial quantitative deficiency | vWF antigen and activity both low in similar proportion; factor VIII normal or low | Often responds to desmopressin, but response should be tested when treatment is planned |
| Type 2A | Loss of high-molecular-weight multimers and reduced platelet binding | Activity lower than antigen; low activity-to-antigen ratio | Treatment often needs more detailed planning than type 1 |
| Type 2B | Increased binding to platelets with loss of large multimers | Activity lower than antigen; platelets sometimes low | Desmopressin is often avoided because it can worsen thrombocytopenia |
| Type 2M | Reduced platelet binding without major multimer loss | Activity lower than antigen; abnormal ratio | Subtype testing separates it from 2A and 2B |
| Type 2N | Poor binding between vWF and factor VIII | Factor VIII disproportionately low compared with vWF antigen | Can resemble hemophilia A and needs different family counseling |
| Type 3 | Near-complete absence of vWF | vWF antigen and activity very low or undetectable; factor VIII often very low | Bleeding risk is high and treatment usually requires vWF concentrate |
Type 1 is the most common form. It usually shows a parallel drop in antigen and activity. Many people with type 1 have mild-to-moderate bleeding, but some have major bleeding after surgery, childbirth, or dental extraction.
Type 2 is a group of function problems. The body produces vWF, but the protein does not work normally. The activity-to-antigen ratio is especially useful here because it shows that function is worse than quantity. Subtype testing matters because type 2B, type 2N, and some type 2A or 2M patterns lead to different treatment decisions.
Type 3 is rare and severe. vWF is absent or almost absent, and factor VIII is often very low. Bleeding includes mucosal bleeding and, in severe cases, joint or muscle bleeding that resembles hemophilia.
Acquired von Willebrand syndrome is separate from inherited VWD. It develops later in life due to another condition or device-related blood flow problem. Examples include certain heart valve diseases, left ventricular assist devices, some lymphoproliferative or plasma cell disorders, autoimmune disease, and severe hypothyroidism. The panel can look similar to VWD, but the history is different: no lifelong bleeding pattern, no family history, and new bleeding in adulthood.
What Results Mean for Bleeding Risk and Procedures
Bleeding risk is not predicted by the panel alone. The best estimate combines laboratory results, personal bleeding history, family history, VWD type, planned procedure, medications, and current health.
The same vWF level creates different practical risk in different situations. A person with vWF activity of 42 IU/dL and no bleeding history after multiple surgeries has lower practical concern than someone with the same activity level, severe nosebleeds, heavy menstrual bleeding, and bleeding after dental work.
Bleeding risk is higher when:
- vWF activity is clearly low, especially below 30 IU/dL
- Factor VIII is low
- The activity-to-antigen ratio suggests type 2 VWD
- vWF is very low or undetectable
- There is past bleeding after surgery, childbirth, dental work, or injury
- Heavy menstrual bleeding has caused iron deficiency or anemia
- Platelet count is low, especially in suspected type 2B VWD
- Aspirin, antiplatelet drugs, anticoagulants, or frequent NSAID use add bleeding risk
- The procedure involves tissues with high fibrinolysis, such as the mouth, nose, uterus, or urinary tract
A normal PT/INR does not guarantee normal bleeding risk in VWD. PT mainly reflects the extrinsic and common clotting pathways. VWD affects platelet adhesion and factor VIII support. The aPTT result is sometimes prolonged when factor VIII is low, but many people with VWD have a normal aPTT.
Procedure planning often includes one or more of the following:
- Desmopressin trial: A supervised test dose checks whether vWF and factor VIII rise enough and stay high enough.
- Tranexamic acid: An antifibrinolytic medicine that helps stabilize clots, especially for dental work, nosebleeds, and heavy menstrual bleeding.
- vWF concentrate: Replacement therapy used when desmopressin is not suitable, response is inadequate, bleeding risk is high, or VWD is severe.
- Iron testing and treatment: Heavy menstrual bleeding and recurrent bleeding often cause iron deficiency.
- Medication review: Aspirin, anticoagulants, antiplatelet drugs, and some NSAIDs need careful review before procedures.
Urgent medical care is needed for bleeding that does not stop with pressure, vomiting blood, black stools, severe headache after head injury, heavy postpartum bleeding, fainting, shortness of breath, chest pain, rapidly expanding swelling, or heavy menstrual bleeding with dizziness or weakness.
Follow-Up Tests, Repeat Testing, and Next Steps
Follow-up depends on the first panel pattern and the bleeding story. A single mildly abnormal panel rarely gives the full answer. Repeat testing is common and appropriate because vWF levels move over time.
Repeat testing is especially useful when:
- Results are between 30 and 50 IU/dL
- Results do not match the bleeding history
- Testing occurred during illness, pregnancy, stress, inflammation, or after surgery
- The sample had handling concerns
- One marker is abnormal but the rest are normal
- The activity-to-antigen ratio suggests type 2 VWD
- A procedure, pregnancy, or surgery needs a clear plan
Common follow-up tests include:
| Follow-up test | What it helps clarify |
|---|---|
| Repeat vWF antigen, vWF activity, and factor VIII | Confirms whether the pattern is persistent at baseline |
| vWF multimer analysis | Shows whether large vWF multimers are missing, especially in type 2A or 2B |
| vWF collagen-binding test | Helps assess function and multimer-related defects |
| Ristocetin-induced platelet aggregation | Helps identify type 2B VWD and distinguish it from platelet-type VWD |
| vWF-factor VIII binding assay | Helps diagnose type 2N VWD |
| Genetic testing | Helps in selected type 2, type 3, family counseling, and unclear cases |
| CBC and platelet count | Checks anemia, platelet number, and thrombocytopenia |
| Ferritin and iron studies | Checks iron deficiency from chronic bleeding |
A platelet count is important because low platelets change the bleeding-risk picture and support certain subtype concerns, especially type 2B VWD. Iron studies matter because chronic heavy menstrual bleeding often causes low ferritin before hemoglobin becomes abnormal.
The next step after diagnosis is not only naming the type. The practical goal is a bleeding plan. People with confirmed VWD or clinically important low vWF should know what to do before dental extraction, surgery, childbirth, injury, or new medications that increase bleeding risk. Many benefit from a written treatment plan from a hematologist.
The plan often includes:
- The VWD type or working diagnosis
- Baseline vWF antigen, vWF activity, and factor VIII levels
- Desmopressin response, if tested
- Medicines to use for minor bleeding
- Medicines to avoid unless specifically approved
- Procedure instructions for dentists, surgeons, obstetric clinicians, and emergency care
- When to use tranexamic acid, desmopressin, or vWF concentrate
- Emergency contact instructions
Women and people who menstruate often need a combined plan that addresses bleeding control, iron deficiency, contraception choices, pregnancy, delivery, and postpartum bleeding. VWD-related heavy menstrual bleeding is treatable, but it is often undertreated when it is dismissed as “normal heavy periods.”
Children need age-specific interpretation. Young children have fewer hemostatic challenges, so they have had fewer chances to show bleeding. A child with a family history and low vWF deserves careful follow-up even when the bleeding history is still limited.
Adults with new bleeding and no lifelong pattern need evaluation for acquired causes, medication effects, kidney or liver disease, platelet disorders, and other clotting problems. Liver disease, vitamin K problems, anticoagulants, and factor deficiencies create different patterns on PT, INR, aPTT, fibrinogen, and factor assays. A targeted approach avoids mislabeling every bleeding symptom as VWD.
References
- ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease 2021 (Guideline)
- ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease 2021 (Guideline)
- Guideline for laboratory diagnosis and monitoring of von Willebrand disease: A joint guideline from the United Kingdom Haemophilia Centre Doctors’ Organisation and the British Society for Haematology 2024 (Guideline)
- Clinical and laboratory diagnosis of von Willebrand disease 2026 (Review)
- Diagnosis and treatment of von Willebrand disease in 2024 and beyond 2024 (Review)
- von Willebrand disease 2024 (Review)
Disclaimer
This article is educational and does not replace medical care from a qualified clinician. Von Willebrand disease testing needs interpretation alongside bleeding history, medications, pregnancy status, inflammation, and repeat results. Seek urgent care for heavy bleeding, bleeding after injury that does not stop, black stools, vomiting blood, severe weakness, fainting, or heavy postpartum bleeding.
